61 results
Page 2 of 4
6-K
EX-99.1
2fsc248f76u7cvq
10 Jun 22
Current report (foreign)
6:05am
F-3/A
6t6k3477khxsw5
20 May 22
Shelf registration (foreign) (amended)
6:54pm
6-K
suwen29d0vqci6
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
6-K
EX-99.1
9pq3bmj9ho21tutme vw
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
6-K
EX-99.2
djxk9olydc
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
F-3
l1o wnr0yunxod
15 Apr 22
Shelf registration (foreign)
5:27pm
6-K
EX-99.1
60ocl9s4
31 Mar 22
Connect Biopharma Reports Full Year 2021 Financial Results
5:15pm
20-F
EX-4.12
0tfdgg
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
aeo0tsfwy
31 Mar 22
Annual report (foreign)
4:33pm
20-F
9t3drc8dj0
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
cah f2bht8
16 Feb 22
Current report (foreign)
4:01pm
6-K
EX-99.2
bf1dv8clftqtrf7 xg4l
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.1
5mfqi
5 Jan 22
Current report (foreign)
5:24pm
6-K
htkh3otc3 vipi
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.1
s7o4oja622q1l00 58
19 Nov 21
Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2 Clinical Trial in Moderate-to-Severe Ulcerative Colitis
4:01pm
6-K
EX-99.1
krrchdhvu
19 Nov 21
Primary endpoint met with all three CBP-201 arms achieving significant improvements
8:00am
6-K
x4tcfmsezt3ztw5jr2
19 Nov 21
Primary endpoint met with all three CBP-201 arms achieving significant improvements
8:00am
6-K
EX-99.1
8yewyphmlp bb
8 Sep 21
Connect Biopharma Announces First Subject Dosed in Phase 2 Trial Evaluating
8:31am
6-K
EX-99.1
yeud88 44
2 Sep 21
Connect Biopharma Announces First Patient Dosed in China Pivotal Trial
4:40pm
6-K
EX-99.1
pvwg ikuyeh
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm